Yunnan Botanee Bio-technology Group Co.,Ltd. — Investor Relations & Filings

Yunnan Botanee Bio-technology Group Co.,Ltd. focuses on the research, development, and commercialization of dermatological products specifically formulated for sensitive skin. The company’s core strategy involves the integration of clinical dermatology with botanical active ingredients derived from high-altitude plant resources. Its flagship brand, Winona, is recognized for its evidence-based approach to skin barrier repair and inflammatory skin conditions. The product portfolio extends to specialized lines including Winona Baby for pediatric care and AOXMED for premium anti-aging solutions. Botanee maintains a strong emphasis on research and development, collaborating with dermatological experts and medical institutions to ensure product safety and efficacy. The company utilizes advanced biotechnology to extract bioactive compounds, positioning its offerings at the intersection of medical science and professional skincare.